Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersSurgery Physician in Baltimore, MD
NPI: 1164452728Primary Practice Location
JOHNS HOPKINS HOSPITAL, THE
1800 Orleans St, Baltimore, MD
Primary Employer
Jhu - Surgery
hopkinsmedicine.org
HQ Phone
Get M.D. Stephen's Phone Numberphone_androidMobile
Get M.D. Stephen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 234 | 306 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 84 | 84 |
| 3 | 32674Removal of lymph nodes of mid-chest cavity using an endoscope | 44 | 44 |
| 4 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 28 | 33 |
| 5 | 32669Removal of a segment of lung tissue using an endoscope | 28 | 28 |
Cardiothoracic surgery educational research and training innovation: A review of 2018-2019.
The Joint Council on Thoracic Surgery Education (JCTSE) "Educate the Educators" Faculty Development Course: Analysis of the First 5 Years.
Authors: Edward Verrier
Publication Date: 2016-02-21
Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Nivolumab, DRUG: Relatlimab
Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Carboplatin, DRUG: Nivolumab, DRUG: Paclitaxel, RADIATION: Radiation, DRUG: Relatlimab
Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Carboplatin, DRUG: Ipilimumab, DRUG: Nivolumab, DRUG: Paclitaxel
